{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":3,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":47,"n_cols":5,"rows_kept":47,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[12,2,12,3],[12,4,12,5],[13,2,13,3],[13,4,13,5],[14,2,14,3],[14,4,14,5],[15,2,15,3],[17,2,17,3],[20,2,20,3],[21,2,21,3],[23,2,23,3],[24,2,24,3],[28,2,28,3],[29,2,29,3],[33,2,33,3],[35,2,35,3],[35,4,35,5],[36,2,36,3],[36,4,36,5],[37,2,37,3],[37,4,37,5],[38,2,38,3],[39,2,39,3],[40,2,40,3],[41,2,41,3],[42,2,42,3],[43,2,43,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA990000439340203316"]
[null,null,"Autore",null,"BOUZAT, Pierre"]
[null,null,"Titolo",null,"Traité de droit pénal et de criminologie : ouvrage couronné par l'Academie des sciences morales et politiques : prix Léon Julliot de la Morandiére / par Pierre Bouzat, Jean Pinatel"]
[null,null,"Pubbl/distr/stampa",null,"Paris : Dalloz, 1975"]
[null,null,"Descrizione fisica",null,"v. ; 25 cm"]
[null,null,"Disciplina",null,"345.44"]
[null,null,"Soggetti",null,"Diritto penale - Francia"]
[{"$nulls":4},"Criminologia - Francia"]
[null,null,"Collocazione",null,"IG XXI 434"]
[null,null,"Lingua di pubblicazione",null,"Francese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910791949003321"]
[null,null,"Autore",null,"Bourne Angela K"]
[null,null,"Titolo",null,"The European Union and the accomodation of Basque differnce [sic] in Spain [[electronic resource] /] / Angela K. Bourne"]
[null,null,"Pubbl/distr/stampa",null,"Manchester, : Manchester University Press"]
[{"$nulls":4},"New York, : Distributed exclusively in the USA by Palgrave, 2008"]
[null,null,"ISBN",null,"1-84779-597-8"]
[{"$nulls":4},"1-78170-134-2"]
[{"$nulls":4},"1-84779-208-1"]
[null,null,"Descrizione fisica",null,"1 online resource (193 p.)"]
[null,null,"Collana",null,"Europe in Change"]
[{"$nulls":4},"Europe in change"]
[null,null,"Disciplina",null,"341.24220899992046"]
[null,null,"Soggetti",null,"Regionalism - Spain"]
[{"$nulls":4},"Nationalism - Spain"]
[{"$nulls":4},"Basques - Spain - Politics and government - 20th century"]
[{"$nulls":4},"Spain Administrative and political divisions"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. [148]-161) and index."]
[null,null,"Nota di contenuto",null,"The impact of European integration on regional power -- Devolution and the accommodation of Basque difference in Spain -- Basque participation in the state's EU decisions -- The Basque presence in Brussels -- More allies, more influence? : the Atlantic Arc and transEuropean networks -- Basque taxation devolution and the EU's competition imperative."]
[null,null,null,"Sommario/riassunto","\"The book explores prospects for an autonomous Basque role in EU politics; institutional arrangements for autonomous community participation in EU decision making; Basque government alliances with other regions and the EU's supranational bodies; EU incentives for collaboration among Basque and central state authorities; the impact of EU decisions on politically sensitive Basque competencies; and the incidence of EU issues in nationalist disputes. It presents a new theoretical framework for analysing the impact of the EU on regional power and will be of interest to students, researchers and general observers of Basque, Spanish and EU politics.\"--Jacket."]
[null,"3.","Record Nr.",null,"UNINA9910220038303321"]
[null,null,"Autore",null,"Domenico De Martinis"]
[null,null,"Titolo",null,"Engineering the Plant Factory for the Production of Biologics and Small-Molecule Medicines"]
[null,null,"Pubbl/distr/stampa",null,"Frontiers Media SA, 2017"]
[null,null,"Descrizione fisica",null,"1 online resource (377 p.)"]
[null,null,"Collana",null,"Frontiers Research Topics"]
[null,null,"Soggetti",null,"Biotechnology"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Sommario/riassunto","Plant gene transfer achieved in the early '80s paved the way for the exploitation of the potential of gene engineering to add novel agronomic traits and/or to design plants as factories for high added value molecules. For this latter area of research, the term \"Molecular Farming\" was coined in reference to agricultural applications in that major crops like maize and tobacco were originally used basically for pharma applications. The concept of the \"green biofactory\" implies different advantages over the typical cell factories based on animal cell or microbial cultures already when considering the investment and managing costs of fermenters. Although yield, stability, and quality of the molecules may vary among different heterologous systems and plants are competitive on a case-to-case basis, still the \"plant factory\" attracts scientists and technologists for the challenging features of low production cost, product safety and easy scale up. Once engineered, a plant is among the cheapest and easiest eukaryotic system to be bred with simple know-how, using nutrients, water and light. Molecules that are currently being produced in plants vary from industrial and pharmaceutical proteins, including medical diagnostics proteins and vaccine antigens, to nutritional supplements such as vitamins, carbohydrates and biopolymers. Convergence among disciplines as distant as plant physiology and pharmacology and, more recently, as omic sciences, bioinformatics and nanotechnology, increases the options of research on the plant cell factory. \"Farming for Pharming\" biologics and small-molecule medicines is a challenging area of plant biotechnology that may break the limits of current standard production "]
[{"$nulls":4},"technologies. The recent success on Ebola fighting with plant-made antibodies put a spotlight on the enormous potential of next generation herbal medicines made especially in the name of the guiding principle of reduction of costs, hence reduction of disparities of health rights and as a tool to guarantee adequate health protection in developing countries.Plant gene transfer achieved in the early '80s paved the way for the exploitation of the potential of gene engineering to add novel agronomic traits and/or to design plants as factories for high added value molecules. For this latter area of research, the term \"Molecular Farming\" was coined in reference to agricultural applications in that major crops like maize and tobacco were originally used basically for pharma applications. The concept of the \"green biofactory\" implies different advantages over the typical cell factories based on animal cell or microbial cultures already when considering the investment and managing costs of fermenters. Although yield, stability, and quality of the molecules may vary among different heterologous systems and plants are competitive on a case-to-case basis, still the \"plant factory\" attracts scientists and technologists for the challenging features of low production cost, product safety and easy scale up. Once engineered, a plant is among the cheapest and easiest eukaryotic system to be bred with simple know-how, using nutrients, water and light. Molecules that are currently being produced in plants vary from industrial and pharmaceutical proteins, including medical diagnostics proteins and vaccine antigens, to nutritional supplements such as vitamins, carbohydrates and biopolymers. Convergence among disciplines as distant as plant physiology and pharmacology and, more recently, as omic sciences, bioinformatics and nanotechnology, increases the options of research on the plant cell factory. \"Farming for Pharming\" biologics and small-molecule medicines is a challenging area of plant biotechnology that may break the limits of current standard production technologies. The recent success on Ebola fighting with plant-made antibodies put a spotlight on the enormous potential of next generation herbal medicines made especially in the name of the guiding principle of reduction of costs, hence reduction of disparities of health rights and as a tool to guarantee adequate health protection in developing countries."]